Company news
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) news
Ekso Bionics Holdings, Inc. news releases on 6ix. Latest, Apr 27, 2023: Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
Press releases — page 2
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
April 26, 2023
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
April 19, 2023
Ekso Bionics Announces Ekso Indego Therapy Order by SoldierStrong
April 16, 2023
Ekso Bionics Reports Fourth Quarter and Year End 2022 Results
March 27, 2023
Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023
March 19, 2023
Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting
February 22, 2023
Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation
December 4, 2022
Ekso Bionics Reports Third Quarter 2022 Results
November 2, 2022
Ekso Bionics to Report Third Quarter 2022 Financial Results on November 3, 2022
October 26, 2022
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 5, 2022
Ekso Bionics Reports Second Quarter 2022 Results
July 27, 2022
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
July 20, 2022
Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
June 12, 2022
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
May 25, 2022
Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference
May 16, 2022
Ekso Bionics Reports First Quarter 2022 Results
April 27, 2022
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
April 20, 2022
Ekso Bionics Reports Fourth Quarter and Year End 2021 Results
February 23, 2022
Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
February 16, 2022
Ekso Bionics Announces Leadership Transition
January 20, 2022
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
January 9, 2022
Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference
January 3, 2022
Ekso Bionics Appoints Corinna E. Lathan, Ph.D. to its Board of Directors
December 27, 2021
Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles
December 15, 2021
Ekso Bionics Reports Third Quarter 2021 Results
November 1, 2021
Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021
October 25, 2021
Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference
September 6, 2021
Ekso Bionics Reports Second Quarter 2021 Results
July 28, 2021
Ekso Bionics to Report Second Quarter 2021 Financial Results on July 29, 2021
July 21, 2021
Ekso Bionics® Announces Expanded Partnership with Kindred Healthcare for Multi-Unit EksoNR Order
May 10, 2021
Ekso Bionics Reports First Quarter 2021 Results
April 28, 2021
Ekso Bionics to Report First Quarter 2021 Financial Results on April 29, 2021
April 21, 2021
Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR
March 8, 2021
Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology
March 2, 2021
Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference
March 1, 2021
Ekso Bionics Reports Fourth Quarter and Year End 2020 Results
February 24, 2021
Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
February 17, 2021
Ekso Bionics Announces Closing of $40 Million Bought Deal Offering
February 10, 2021
Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million
February 7, 2021
Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock
February 7, 2021
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results
January 12, 2021
Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference
January 4, 2021
Ekso Bionics’ Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors
December 29, 2020
Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company
November 9, 2020
Ekso Bionics Reports Third Quarter 2020 Results
October 28, 2020
Ekso Bionics Announces EGM Builders as First Customer to Adopt EVO Technology
October 28, 2020
Ekso Bionics® to Report Third Quarter 2020 Financial Results on October 29, 2020
October 21, 2020
Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020
September 8, 2020
Ekso Bionics® Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use
August 19, 2020
Ekso Bionics Reports Second Quarter 2020 Results
July 29, 2020